X

Global Reach

Continued strict control measures needed to reduce new COVID-19 strains

Calls on governments to consider the continued use of strict control measures as the only way to reduce the evolution…

Antibiotic potential for cannabis molecule

Research establishes antibiotic potential for cannabis molecule: Synthetic cannabidiol, better known as CBD, has been shown for the first time…

Sabin Vaccine Institute researchers to investigate COVID-19 misinformation

Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance. The Sabin Vaccine Institute (Sabin)…

DigiHEST: How we reached 29 countries in two days

DigiHEST: How we reached 29 countries in two days: The David Nott Foundation recently completed our first digital, live-streamed surgical…

Science scepticism may be reinforced by UK rush to approve vaccines

COVID-19: Science scepticism may be reinforced by UK rush to approve vaccines: Former director of public health Professor John Ashton…

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK: The University of Oxford welcomes the news that the UK…

WHO issues validation for a COVID-19 vaccine

WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access: The World…

Things we know at the end of 2020 (part 2)

Things we know at the end of 2020 (part 2): From lockdowns and travels bans to isolation and testing queues,…

Antimicrobial resistant diseases outside of EU

Surveillance of antimicrobial resistant diseases could be more challenging outside of the European Union: In a new report from the…

Things we know at the end of 2020 (part 1)

2020, what a year! Melbourne University researchers, Zena Cumpston, Professor Andrew Dawson, Professor Peter Doherty AC, and Professor Guay Lim…

This website uses cookies.